Mylan may sweeten terms for Perrigo deal

Pharma group chairman told investors he may sweeten the company’s offer for Irish headquartered company by adding terms to reduce the risk to its shareholders





YOU MAY ALSO LIKE...

Common Ground

How does a post-Brexit world shape the identity and relationship of these islands